Related Experiment Videos
[Clinical evaluation of fluoxetine]
S Puzyński1, J Rybakowski, J Kocur
1II Kliniki Psychiatrycznej, Instytutu Psychiatrii i Neurologii w Warszawie.
Psychiatria Polska
|September 1, 1994
Summary
Fluoxetine (Prozac) is effective for psychogenic depressions and potentially for drug-resistant endogenous depressions. Most patients tolerated the antidepressant well, with few side effects reported.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Medicine
Context:
- Multicenter trials involving 86 inpatient participants with depression.
- Focus on treatment efficacy and patient tolerance of fluoxetine.
- Specific attention to endogenous and psychogenic depression subtypes.
Purpose:
- To evaluate the effectiveness of fluoxetine (Prozac) in treating depression.
- To assess the tolerability and side effect profile of fluoxetine.
- To determine fluoxetine's efficacy in different depression subtypes, including drug-resistant cases.
Summary:
- Fluoxetine demonstrated significant efficacy in managing psychogenic depressions.
- The antidepressant showed potential utility in endogenous depressions, including treatment-resistant forms.
- Satisfactory tolerability was observed in 62% of patients; common side effects included sleep disturbances, anxiety, appetite loss, and nausea.
Impact:
- Provides evidence for fluoxetine's role in managing specific depressive disorders.
- Highlights the drug's generally favorable safety profile in clinical settings.
- Informs clinical decision-making regarding antidepressant selection for depressed inpatients.